跳至主要内容
临床试验/NCT03826199
NCT03826199已完成4 期

Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town, South Africa (Formative Study)

University of California, Los Angeles1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年8月23日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
PrEP Retention

研究概览

简要总结

The overarching goal of this proposal is to evaluate the feasibility and acceptability of integrating PrEP into antenatal and postnatal care, to describe the cascade in women initiating PrEP in this setting, and to evaluate the reasons for attrition along the PrEP cascade in a cohort of pregnant and breastfeeding women. The specific aims are to: (1) Evaluate the feasibility and acceptability of integrating PrEP into antenatal and postnatal/well-baby services; (2) Describe the PrEP cascade of initiation, retention, and adherence in a cohort of 220 HIV-uninfected pregnant and breastfeeding women, (3) Evaluate attrition and associated factors across the PrEP cascade.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Documented HIV-negative according to two fingerpick rapid tests (per routine antenatal care protocol in this setting), confirmed with a 4th generation antigen HIV test at study enrollment
  • No previous exposure triple-drug antiretroviral therapy
  • Age 18 years or older
  • Lives within 20 kilometers of a clinic
  • Without psychiatric or medical contraindications to PrEP use
  • Able to provide informed consent for research

排除标准

  • Failure to meet any of the inclusion criteria

结局指标

主要结局

PrEP Retention

时间窗: 18 months

number of women on PrEP who return for study visits (do not miss more than 1 visit) / total number of women in active cohort who are prescribed PrEP

PrEP Adherence

时间窗: 3 months

number of women taking PrEP who have \>80 percent levels at \>40ng/mL tenofovir diphosphate (indicating dosing in past 24 hours) / total woman-time on PrEP in active cohort = PrEP adherence rate (objective)

次要结局

  • PrEP Initiation(18 months)
  • PrEP Adherence (Peri-sexual)(3 months)
  • PrEP Adherence (Subjective, Self-reported)(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dvora Joseph Davey, PhD, MPH

Principal Investigator

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验